Table 1. Correlation of clinico-pathological features with ALDH1B1 expression levels in 40 OS patients.
| Clinicopathological features | No. of cases (%) | ALDH1B1 | P-value | ||
|---|---|---|---|---|---|
| Low (%) | High (%) | ||||
| Age (years) | ≤median | 20(50.0) | 13 | 11 | 0.518 |
| >median | 20(50.0) | 7 | 9 | ||
| Gender | Male | 27 | 15 | 12 | 0.311 |
| Female | 13 | 5 | 8 | ||
| Tumor site | Femur | 19 | 10 | 9 | 0.909 |
| Tibia | 12 | 5 | 7 | ||
| other | 9 | 5 | 4 | ||
| TNM satge | Stage I | 12 | 9 | 3 | 0.027 |
| Stage II | 24 | 11 | 13 | ||
| Stage III | 4 | 0 | 4 | ||
| Metastasis | Absent | 15 | 11 | 4 | 0.006 |
| Present | 25 | 9 | 16 | ||
| Recurrence | Absent | 25 | 14 | 11 | 0.327 |
| Present | 15 | 6 | 9 | ||
| Tumor size | ≥7.5cm | 32 | 13 | 19 | 0.001 |
| ≤7.5cm | 8 | 7 | 1 | ||
| Survival | Live | 20 | 15 | 5 | 0.001 |
| Dead | 20 | 5 | 15 | ||